1.Suggestions on the sustainable application of appropriate medical technologies in rural areas of Ningxia Hui Autonomous Region
Xueguang CUI ; Wensheng ZHANG ; Xueping ZHANG ; Xiuying DAI
Chinese Journal of Medical Science Research Management 2010;23(3):159-162
In this paper, we investigated five model counties for their application of medical technologies to explore the mechanism for sustainable development of appropriate medical technologies in rural areas of Ningxia, The investigation involved the governmental role at all levels in the choice of appropriate technologies, the funding system, the stimulation system and the evaluation system.
2.The effect of HO-1 activated via P38? pathway in the genesis and chemotherapy resistance of breast carcinoma
Yingjiang YE ; Shan WANG ; Feifei YAN ; Xueguang ZHU ; Xinmin QIAO ; Deqi YANG ; Zhirong CUI
Chinese Journal of General Surgery 1993;0(03):-
Objective To investigate the role of p38? pathway and HO-1 in the genesis and chemotherapy resistance of breast cancer. Methods The proliferation and apoptosis of human breast cancer cells were examined by MTT assay. The expression of p38? and HO-1 mRNA were examined by RT-PCR. Results The p38? mRNA level in 78% of samples was significantly greater than that in the normal tissue and the p38? mRNA level in patients with lymph node metastasis was higher than that without lymph node metastasis (P
3.Significance of MEK-ERK cascade in the development of human breast carcinoma.
Shu WANG ; Shan WANG ; Xueguang ZHU ; Jiaqing ZHANG ; Xinmin QIAO ; Yingjiang YE ; Bin LIANG ; Xiangtao MA ; Zhirong CUI
Chinese Journal of Surgery 2002;40(3):171-174
OBJECTIVETo investigate the MEK and ERK expression and their relationship with clinicopathological parameters in human breast carcinoma, and the effect of preoperative chemotherapy on MEK and ERK protein expression.
METHODSSamples were obtained from 56 patients with breast carcinoma and 8 patients with benign tumors. Sixteen of the 56 patients received preoperative chemotherapy. Western blot and immunohistochemistry were used to measure the expression of MEK1, MEK2 and ERK1, ERK2 protein.
RESULTSMEK2 and ERK1, ERK2 protein levels were increased in breast carcinoma tissue compared with those in adjacent normal tissues (t = 7.244, 5.959, 3.735, P < 0.01) and benign tumors (t = 2.206, P < 0.05). The levels of MEK1 were decreased. The expression of MEK2 protein in ER negative patients was higher than that in ER positive ones. MEK2 protein levels were lower in patients who received preoperative chemotherapy than in those who did not.
CONCLUSIONOverexpression of MEK-ERK may play an important role in the development of human breast carcinoma. MEK and ERK protein expressions are inhibited by preoperative chemotherapy.
Adult ; Aged ; Blotting, Western ; Breast Neoplasms ; diagnosis ; enzymology ; metabolism ; Female ; Humans ; Immunohistochemistry ; MAP Kinase Kinase 1 ; MAP Kinase Kinase 2 ; MAP Kinase Signaling System ; physiology ; Middle Aged ; Mitogen-Activated Protein Kinase 1 ; metabolism ; Mitogen-Activated Protein Kinase 3 ; Mitogen-Activated Protein Kinase Kinases ; metabolism ; Mitogen-Activated Protein Kinases ; metabolism ; Prognosis ; Protein Kinases ; metabolism ; Protein-Serine-Threonine Kinases ; metabolism ; Protein-Tyrosine Kinases ; metabolism